Welcome to the HIV Studies Page

CURRENT STUDIES THAT MAY INTEREST YOU

MyPaTH Story Booth 2.0

Interested in sharing your story about health, illness, or research? Patients and caregivers are needed to participate in a research study to help learn more about topics that are important to you and that may improve health and health care. Participation involves one 45-minute session that takes place over the phone. Eligible participants must be able to read and understand English.

ACL Tear

DURATION: 45 minutes

VISITS: 1 visit or phone call

LOCATION: By phone

COMPENSATION: NONE

Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis

This research study is testing a PrEP drug, MK-8527, in people who could be exposed to HIV-1. The purpose of this trial is to test the safety of the trial drug, MK-8527 compared to emtricitabine/tenofovir (FTC/TDF) and to also see how well MK-8527 works to reduce the chance of getting HIV-1 infection compared to FTC/TDF. Study participation involves about one visit/month over 3 years.

Healthy Volunteer

HIV

AGE: 18 and older

DURATION: 3 years

VISITS: visits are about once a month.

LOCATION: UPMC Magee Clinical and Translational Research Center (MWH CTRC) - Oakland

COMPENSATION: YES

REGISTRY

HIV Prevention Research Registry

Are you interested in learning about HIV prevention research studies taking place at the University of Pittsburgh and UPMC? If so, you can join the HIV Prevention Research Registry. HIV prevention registry members may be contacted by registry staff members about studies for which they appear to qualify. Eligible participants are ages 18 and older.

DURATION: Ongoing

LOCATION: University of Pittsburgh

COMPENSATION: NONE

HPTN 106

Are you an HIV-negative man who is comfortable discussing your sexual history with researchers? If so, you may be able to participate in a research study to compare the safety and acceptability of a rectal douche containing tenofovir to a pill that prevents HIV. Participation involves about 8 visits over approximately 19 weeks. Compensation provided.

AGE: 18 and older

SEX: Male

DURATION: about 19 weeks

VISITS: 8

LOCATION: UPMC Magee Clinical and Translational Research Center (MWH CTRC) - Oakland

COMPENSATION: will be provided

REGISTRY

NO IN-PERSON VISITS

HIV Research Registry

Are you interested in studies related to the treatment and prevention of HIV/AIDS and related conditions? HIV Research Registry members may be contacted by registry staff about studies for which they appear to qualify. Eligible participants are ages 18 and older.

DURATION: Ongoing

VISITS: 1 screening survey

LOCATION: Online

COMPENSATION: NONE

RELATED RESEARCH AREAS:

Immune System/Infections